Everyone experiences nosebleeds at some point, but nosebleeds with no known cause can be a sign of hemophilia, according to the American Academy of Pediatrics (AAP). This can happen when a blood ...

Patients with hemophilia across the spectrum still face regular challenges like frequent bleeding episodes, joint damage, and chronic pain, which negatively impact their quality of life.

Even with two diagnosed bleeding disorders, columnist Jennifer Lynne still hesitates to identify a bleed due to years of medical dismissal.

Oct. 14, 2024 – The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of ...

Key Takeaways Marstacimab significantly reduced annualized bleeding rate by 93% in severe hemophilia A or B patients with inhibitors over 12 months. The treatment is approved in the US and Europe ...

BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and ...

WEDNESDAY, April 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ...

Pfizer Inc. (PFE) on Thursday said that its therapy Hympavzi demonstrated improvement in bleeding outcomes for adults and adolescents living with hemophilia A or B with inhibitors in a late-stage ...

A soon-to-be-released documentary film aims to change the conversation around hemophilia, a condition in which many female ...